Literature DB >> 26362204

Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy.

Cristina Chimenti1, Fernanda Scopelliti2, Elisabetta Vulpis3, Marco Tafani4, Lidia Villanova4, Romina Verardo3, Ruggero De Paulis5, Matteo A Russo6, Andrea Frustaci7.   

Abstract

Cardiac dysfunction of Fabry disease (FD) has been associated with myofilament damage and cell death as result of α-galactosidase A deficiency and globotriaosylceramide accumulation. We sought to evaluate the role of oxidative stress in FD cardiomyocyte dysfunction. Myocardial tissue from 18 patients with FD was investigated for the expression of inducible nitric oxide synthase (iNOS) and nitrotyrosine by immunohistochemistry. Western blot analysis for nitrotyrosine was also performed. Oxidative damage to DNA was investigated by immunostaining for 8-hydroxydeoxyguanosine (8-OHdG), whereas apoptosis was evaluated by in situ ligation with hairpin probes. iNOS and nitrotyrosine expression was increased in FD hearts compared with hypertrophic cardiomyopathy and normal controls. Remarkably, immunostaining was homogeneously expressed in FD male cardiomyocytes, whereas it was only detected in the affected cardiomyocytes of FD females. Western blot analysis confirmed an increase in FD cardiomyocyte protein nitration compared with controls. 8-OHdG was expressed in 25% of cardiomyocyte nuclei from FD patients, whereas it was absent in controls. The intensity of immunostaining for iNOS/nitrotyrosine correlated with 8-OHdG expression in cardiomyocyte nuclei. Apoptosis of FD cardiomyocytes was 187-fold higher than in controls, and apoptotic nuclei were positive for 8-OHdG. Cardiac dysfunction of FD reflects increased myocardial nitric oxide production with oxidative damage of cardiomyocyte myofilaments and DNA, causing cell dysfunction and death.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac dysfunction; Cardiomyopathy; Cell death; Fabry disease; Oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 26362204     DOI: 10.1016/j.humpath.2015.07.017

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  Oxidative stress biomarkers in Fabry disease: is there a room for them?

Authors:  C Simoncini; S Torri; V Montano; L Chico; F Gruosso; A Tuttolomondo; A Pinto; I Simonetta; V Cianci; A Salviati; V Vicenzi; G Marchi; D Girelli; D Concolino; S Sestito; M Zedde; G Siciliano; Michelangelo Mancuso
Journal:  J Neurol       Date:  2020-07-27       Impact factor: 4.849

2.  Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Authors:  Paul J M Wijnker; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

3.  Fabry disease - a genetically conditioned extremely rare disease with a very unusual course.

Authors:  Mirosław Śnit; Marcela Przyłudzka; Władysław Grzeszczak
Journal:  Intractable Rare Dis Res       Date:  2022-02

Review 4.  Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration.

Authors:  Sarah Thompson; Beatriz Martínez-Burgo; Krishna Mohan Sepuru; Krishna Rajarathnam; John A Kirby; Neil S Sheerin; Simi Ali
Journal:  Int J Mol Sci       Date:  2017-08-03       Impact factor: 5.923

5.  Serum Bilirubin Levels and Promoter Variations in HMOX1 and UGT1A1 Genes in Patients with Fabry Disease.

Authors:  Alena Jirásková; Giulia Bortolussi; Gabriela Dostálová; Lenka Eremiášová; Lubor Golaň; Vilém Danzig; Aleš Linhart; Libor Vítek
Journal:  Oxid Med Cell Longev       Date:  2017-08-16       Impact factor: 6.543

6.  Characterization of small fiber pathology in a mouse model of Fabry disease.

Authors:  Lukas Hofmann; Dorothea Hose; Anne Grießhammer; Robert Blum; Frank Döring; Sulayman Dib-Hajj; Stephen Waxman; Claudia Sommer; Erhard Wischmeyer; Nurcan Üçeyler
Journal:  Elife       Date:  2018-10-17       Impact factor: 8.140

7.  Voluntary wheel running activates Akt/AMPK/eNOS signaling cascades without improving profound endothelial dysfunction in mice deficient in α-galactosidase A.

Authors:  Justin J Kang; Taylour A Treadwell; Peter F Bodary; James A Shayman
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

Review 8.  Electrocardiographic Changes and Arrhythmia in Fabry Disease.

Authors:  Mehdi Namdar
Journal:  Front Cardiovasc Med       Date:  2016-03-24

9.  [Association of Inorganics Accumulation with the Activation of NF-κB Signaling Pathway and the iNOS Expression of Lung Tissue in Xuanwei Lung Cancer Patients].

Authors:  Jiapeng Yang; Guangjian Li; Yunchao Huang; Lianhua Ye; Yongchun Zhou; Guangqiang Zhao; Yujie Lei; Xiaobo Chen; Kun Wang; Ying Chen; Chun Dai; Yanjun Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-01

10.  Inhibition of Mitochondrial Complex I Impairs Release of α-Galactosidase by Jurkat Cells.

Authors:  Jonathan R A Lambert; Steven J Howe; Ahad A Rahim; Derek G Burke; Simon J R Heales
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.